Global Healthcare Leaders Back iKure With USD 1.8 Million to Expand Primary Care Across India

iKure Techsoft has raised USD 1.8 million in a pre-Series A funding round to expand its technology-enabled primary healthcare network in India. The round includes support from Philips Foundation, World Diabetes Foundation, Bayer Foundation through We Share Forward, and Japan-based Prourgn LLC.

The funding is notable because iKure is not building a healthcare app only for urban smartphone users. Its model combines community health workers, clinics, diagnostics, pharmacies, telemedicine, and digital patient records to serve rural and semi-urban communities.

What iKure does

iKure was founded in 2010 by Sujay Santra.

The Kolkata-based health-tech company focuses on primary healthcare, which means the first level of care people need for common illnesses, health checks, long-term condition monitoring, and referrals to specialists when required.

The company uses its digital platform, called WHIMS, to help health workers and clinical teams record patient information, track follow-ups, and manage care over time.

For example, a person diagnosed with high blood pressure may need more than one consultation. They may require regular checks, medicine reminders, and follow-up support. iKure’s model aims to keep such patients connected to local health workers and medical services instead of treating one visit as the end of care.

According to iKure, it operates across 11 states, reaches 7,900 villages, and has recorded more than 4.5 million patient interactions. These figures are company-reported.

Why iKure needs the funding

Healthcare expansion requires more than writing better software. To reach underserved areas, iKure needs trained health workers, physical hubs, clinics, diagnostic facilities, pharmacy support, and systems that can work reliably in different local conditions.

As per the company’s funding announcement, the USD 1.8 million will be used to expand its workforce and strengthen healthcare hubs, clinics, pharmacies, and diagnostics. A part of the funding will also go towards improving WHIMS with AI-enabled clinical decision support.

This means the software may help health workers identify cases that need faster attention and help clinical teams manage follow-ups across a larger population. It is a support tool for care teams, not a replacement for doctors or medical judgment.

The company also plans to invest in remote patient monitoring and workforce development. Both are important for conditions such as diabetes, hypertension, and maternal health, where regular follow-up can matter as much as the first diagnosis.

The larger aim behind iKure

India has improved access to screenings and consultations in many areas. The tougher challenge is ensuring that people receive continuous care after that first interaction.

iKure’s main aim is to reduce this gap. Its approach is built around local health workers who know their communities and can work with digital records that continue from one visit to the next.

The funding may help the startup deepen this model rather than move into an unrelated business. It is also a sign that global health-focused organizations see potential in technology that supports real-world healthcare delivery, not just online appointments.

Competitors and the healthcare space

iKure operates in a broad primary-healthcare and rural-health-tech market. Karma Healthcare is one comparable player that has used nurse-assisted telemedicine clinics in rural and semi-urban regions.

However, iKure’s model is wider than a telemedicine service alone. It combines local health workers, care hubs, digital records, diagnostics, and follow-up systems. Its biggest challenge will be maintaining service quality as it expands across more communities and states.

Key takeaways –

iKure’s USD 1.8 million pre-Series A funding will help it grow a technology-enabled primary healthcare model for underserved regions of India. The company plans to invest in people, clinics, diagnostics, digital tools, and patient follow-up systems.

For patients, the potential value is simple – healthcare that stays connected after the first check-up. For iKure, the next stage is about scaling carefully while keeping local care and trust at the centre of its model.

Facts Input- UNIIndia, Philips Foundation, PMC